0
Rhythm Pharmaceuticals, Inc. Banner Image

Rhythm Pharmaceuticals, Inc.

  • Ticker RYTM
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Rhythm Pharmaceuticals, Inc. Logo Image
  • 51-200 Employees
  • Based in Boston, Massachusetts
Rhythm is a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic disorders of obesity. Rhythm’s lead product candidate is setmelanotide, a first-in-class melanocortin-4 receptor (MC4R) agonist. Rhythm supports The Genetic Obesity Project (GeneticObesity.com) and the GO-ID Genotyping Study (GeneticObesityID.com).
Rhythm Pharmaceuticals, Inc.

Most Recent Annual Report

Rhythm Pharmaceuticals, Inc.
MOST RECENT 2021 Annual Report and Form 10K

Older/Archived Annual Reports